No earnings within 2 weeks of this transaction.
| Insider | Venker Eric |
|---|---|
| Title | President & Immunovant CEO |
| Transaction Date | Dec 24, 2025 |
| Expiration Date | Apr 19, 2032 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Dec 30, 2025 |
| Document Date | Dec 23, 2025 |
| Shares Purchased | 117,848 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 5,444,834 |
| Derivative | Derivative |
| Accession Number | 0001140361-25-046786 |
| Document | View SEC Filing |